证券代码：300622 证券简称：博士眼镜 博士眼镜连锁股份有限公司 投资者关系活动记录表 编号：2022-014 | --- | --- | --- | --- | --- | --- | --- | |------------------------------|-------------------------------------------------------------------------------------|----------------------------------------------------|-------|-------|---------------------------------------------------------------------------------------------------------------|-------| | | ■ 特定对象调研 | □ 分析师会议 | | | | | | | □ 媒体采访 | □ 业绩说明会 | | | | | | 投资者关系活 动类别 | □ 新闻发布会 | □ 路演活动 | | | ...

证券代码：300622 证券简称：博士眼镜 博士眼镜连锁股份有限公司 投资者关系活动记录表 编号：2022-010 | --- | --- | --- | |--------------|------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | | ■ 特定对象调研 | □ 分析师会议 | | | □ 媒体采访 | □ 业绩说明会 | | 投资者关系活 | □ 新闻发布会 | □ 路演活动 | | 动类别 | □ 现场参观 | | | | ■ 其他 电话会议 | | | 参与单位名称 | | 国泰君安、招商证券、国寿养老、新华基金、汇丰晋信、华宝 | | 及人员姓名 | 基金、太保基金 | | | 时间 | 2022 年 6 月 7 日 | | | 地点 | ...

证券代码：300622 证券简称：博士眼镜 博士眼镜连锁股份有限公司 投资者关系活动记录表 编号：2022-008 | --- | --- | --- | |-------------------------|-------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | ■ 特定对象调研 | □ 分析师会议 | | | □ 媒体采访 | □ 业绩说明会 | | 投资者关系活 动类别 | □ 新闻发布会 ■ 现场参观 ■ 其他 电话会议 | □ 路演活动 | | 参与单位名称 及人员姓名 | | 方正证券、中加基金、聚鸣投资、健顺投资、交银施罗德、华 富基金、光大保德信、浦银安盛、天弘基金、嘉实基金、博道 基 ...

证券代码：300622 证券简称：博士眼镜 博士眼镜连锁股份有限公司 投资者关系活动记录表 编号：2022-019 | --- | --- | --- | --- | --- | --- | --- | |-------------------------|--------------------------------------------------------|----------------------------------------------------|----------|-------|-------|------------------| | | 特定对象调研 | 分析师会议 | | | | | | | ■ □ 媒体采访 | □ □ 业绩说明会 | | | | | | 投资者关系活 | □ 新闻发布会 | □ 路演活动 | | | | | | 动类别 | □ 现场参观 | | | | | | | | ■ 其他 电话会议 | | | | | | | 参与单位名称 及人员姓名 | 财通基金、民生证券 | | | | | | | 时间 | 2022 年 8 月 31 日 15:30-16: ...

证券代码：300622 证券简称：博士眼镜 博士眼镜连锁股份有限公司 投资者关系活动记录表 编号：2022-018 | --- | --- | --- | |--------------|------------------------------------|----------------------------------------------------------| | | ■ 特定对象调研 | □ 分析师会议 | | | □ 媒体采访 | □ 业绩说明会 | | 投资者关系活 | □ 新闻发布会 | □ 路演活动 | | 动类别 | □ 现场参观 | | | | ■ 其他 电话会议 | | | | | 上海国泰君安证券资产管理有限公司、兴业证券、西部利得基 | | | | 金管理有限公司、阳光资产管理股份有限公司、苏州君榕资产 | | | | 管理有限公司、中加基金管理有限公司、上海鸿涵投资管理有 | | | | 限公司、博道基金管理有限公司、中国人保资产管理有限公司、 | | | 民生通惠资产管理有限公司、 | RAYS CAPITAL PARTNERS | | | LIMITED | 、深圳 ...

编号：2022-020 ■特定对象调研 □分析师会议 □媒体采访 □业绩说明会 投资者关系活 □新闻发布会 □路演活动 动类别 □现场参观 ■其他 电话会议 、策略会 参与单位名称 证券代码：300622 证券简称：博士眼镜 博士眼镜连锁股份有限公司 投资者关系活动记录表 嘉实基金、中信建投、民生证券、兴业证券、淳厚基金等机构 | --- | --- | |-----------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | 及人员姓名 | | | 时间 | 2022 年 9 月 6 日、 2022 年 9 月 7 日、 2022 年 9 月 9 日 | | 地点 | 公司会议室 | | 上市公司接待 人员姓名 | 董事、董事会秘书、副总经理：杨秋 副总经理、财务总监：张晓明 投 ...

证券代码：300622 证券简称：博士眼镜 公告编号：2022-066 博士眼镜连锁股份有限公司 关于参加深圳辖区上市公司 2022 年投资者 网上集体接待日活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流工作，博士眼镜连锁股份有限公司（以下 简称"公司"）将参加由深圳证监局指导、深圳上市公司协会与深圳市全景网络 有限公司联合举办的"2022 年深圳辖区上市公司投资者集体接待日活动"，现将 相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演"网站 （http://rs.p5w.net），或关注微信公众号：全景财经，或下载全景路演 APP,参 与本次互动交流，活动时间为 2022 年 11 月 9 日（周三）16：30-17：30。届时, 公司的董事会秘书杨秋女士、财务总监张晓明先生将在线就公司业绩、公司治理、 发展战略、经营状况、股权激励和可持续发展等投资者关心的问题，与投资者进 行沟通与交流，欢迎广大投资者踊跃参与！ 特此公告。 博士眼镜连锁股份有限公司 董事会 二〇二二年十一月三日 1 ...

证券代码：300622 证券简称：博士眼镜 博士眼镜连锁股份有限公司 投资者关系活动记录表 编号：2022-021 | --- | --- | --- | --- | --- | --- | --- | |-----------------------|--------------------------------------------------------|--------------|----------------------------------|-------|-------|------------------| | | | | | | | | | | ■ 特定对象调研 | □ 分析师会议 | | | | | | | □ 媒体采访 | □ 业绩说明会 | | | | | | 投资者关系活 | □ 新闻发布会 | □ 路演活动 | | | | | | 动类别 | □ 现场参观 | | | | | | | | ■ 其他 电话会议 | | | | | | | | 上海国泰君安证券资产管理有限公司、 | | | | | VALUE PARTNERS | | | HONG KONG LIMITED ...

博士眼镜连锁股份有限公司 2022 年第三季度报告 证券代码：300622 证券简称：博士眼镜 公告编号：2022-065 博士眼镜连锁股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报 告中财务信息的真实、准确、完整。 3.第三季度报告是否经过审计 □是 否 1 博士眼镜连锁股份有限公司 2022 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 | | 本报告期 | 本报告期比上年 | 年初至报告期末 | 年初至报告期末 | | --- | --- | --- | --- | --- | | | | 同期增减 | | 比上年同期增减 | | 营业收入（元） | 273,852,165.91 | 13.67% | 731,083,758.74 | 10.32% | ...

Financial Performance - The company's operating revenue for the first half of 2022 was approximately ¥457.23 million, representing an increase of 8.40% compared to ¥421.80 million in the same period last year[19]. - The net profit attributable to shareholders for the first half of 2022 was approximately ¥20.19 million, a decrease of 55.21% from ¥45.07 million in the previous year[19]. - The net profit after deducting non-recurring gains and losses was approximately ¥15.21 million, down 62.25% from ¥40.30 million in the same period last year[19]. - The net cash flow from operating activities was approximately ¥91.95 million, a decline of 19.43% compared to ¥114.12 million in the previous year[19]. - The total assets at the end of the reporting period were approximately ¥975.54 million, a decrease of 1.25% from ¥987.93 million at the end of the previous year[19]. - The net assets attributable to shareholders decreased by 7.71% to approximately ¥607.16 million from ¥657.89 million at the end of the previous year[19]. - The basic earnings per share for the first half of 2022 was ¥0.12, down 55.56% from ¥0.27 in the same period last year[19]. - The diluted earnings per share was ¥0.12, a decrease of 53.85% from ¥0.26 in the previous year[19]. - The weighted average return on net assets was 3.02%, down 4.23% from 7.25% in the previous year[19]. - The company's operating profit decreased by 57.74% year-on-year to CNY 23.85 million, while net profit attributable to shareholders fell by 55.21% to CNY 20.19 million[43]. Market and Operational Strategy - The company operates six major eyewear store brands, including "President optical" and "博士眼镜," targeting various market segments[27]. - The eyewear retail market in China grew from ¥528 billion in 2012 to ¥900 billion in 2021, with a compound annual growth rate of 7.83%[35]. - The proportion of the population aged 60 and above in China reached 18.9% by the end of 2021, indicating a growing demand for progressive multifocal lenses[34]. - The company has established partnerships with channels like Sam's Club and duty-free shops to create optical centers, enhancing market reach[27]. - The company utilizes a centralized procurement model to optimize inventory and supplier management, ensuring efficient operations[29]. - The online sales strategy includes official flagship stores on e-commerce platforms and promotional activities on social media to drive customer engagement[31]. - The company emphasizes a one-stop service for consumers, including eye health records and follow-up services, enhancing customer loyalty[27]. - The demand for functional eyewear has increased due to rising vision health issues among different age groups, particularly among children and the elderly[34]. - The company is actively expanding its store network in core consumer areas and exploring opportunities in lower-tier markets, including the Pearl River Delta and Yangtze River Delta regions[44]. - The company has partnered with public hospitals to advance a new model of comprehensive vision care services, focusing on myopia prevention and control[42]. Challenges and Risks - The company has seen a significant impact on store revenue due to pandemic-related restrictions, particularly in key regions like Guangdong and Jiangsu[43]. - The government’s focus on vision health has increased demand for myopia prevention products, presenting both opportunities and challenges for the eyewear retail industry[39]. - The ongoing COVID-19 pandemic continues to affect operations, with the company closely monitoring the situation and adjusting strategies to mitigate risks[98]. - The company acknowledges the risk of intense market competition in the eyewear retail industry, which has a low concentration and regional differentiation[98]. - Rising operational costs, including rent and labor, are anticipated, prompting the company to strengthen internal management and cost control[100]. Investment and Growth Initiatives - The company is actively seeking investment opportunities in the optical industry, having established an investment fund in collaboration with Nanjing Steel Group[54]. - The company aims to enhance its supply chain management by optimizing its franchise platform and improving delivery efficiency for customized products[47]. - The company is exploring potential mergers and acquisitions to enhance market presence and operational efficiency[189]. - The company plans to enhance its online sales platform, targeting a 20% increase in e-commerce revenue by the end of the fiscal year[189]. - The company is investing in new technology development, with a budget allocation of 1.3 million yuan for R&D initiatives[187]. Corporate Governance and Social Responsibility - The company is committed to fulfilling its social responsibilities and environmental commitments[114]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[115]. - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties during the reporting period[122]. - The company has maintained compliance with relevant laws and regulations to protect investor rights and improve governance[116]. - The company donated 500 pairs of protective glasses to the Women's Federation in Xi'an and 230 pairs to the Luohu District in Shenzhen during the COVID-19 pandemic[118]. Future Outlook - Future outlook includes potential market expansion and new product development, although specific figures and timelines were not disclosed in the report[176]. - The company plans to continue expanding its market presence and product offerings in the upcoming periods[1]. - The company aims to strengthen its investment strategies and external partnerships to drive growth[1]. - The company is actively pursuing opportunities for growth in both domestic and international markets[200].